Literature DB >> 27300172

Biological imaging in clinical oncology-introduction.

Yasumasa Nishimura1.   

Abstract

Year:  2016        PMID： 27300172     DOI： 10.1007/s10147-016-0999-4

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  16 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

Review 2.  Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.

Authors:  Bianca A W Hoeben; Johan Bussink; Esther G C Troost; Wim J G Oyen; Johannes H A M Kaanders
Journal:  Acta Oncol       Date:  2013-09-05       Impact factor: 4.089

3.  Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

Authors:  W J Koh; J S Rasey; M L Evans; J R Grierson; T K Lewellen; M M Graham; K A Krohn; T W Griffin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

4.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.

Authors:  Edmond H N Pow; Dora L W Kwong; Anne S McMillan; May C M Wong; Jonathan S T Sham; Lucullus H T Leung; W Keung Leung
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-15       Impact factor: 7.038

5.  FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.

Authors:  David L Schwartz; Eric C Ford; Joseph Rajendran; Bevan Yueh; Marc D Coltrera; Jeffery Virgin; Yoshimi Anzai; David Haynor; Barbara Lewellen; David Mattes; Paul Kinahan; Juergen Meyer; Mark Phillips; Michael Leblanc; Kenneth Krohn; Janet Eary; George E Laramore
Journal:  Head Neck       Date:  2005-06       Impact factor: 3.147

Review 6.  Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis.

Authors:  Guozeng Xu; Junkai Li; Xiaoyan Zuo; Chunyan Li
Journal:  Laryngoscope       Date:  2012-07-02       Impact factor: 3.325

7.  FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.

Authors:  Michael Zimny; Bernd Gagel; Ercole DiMartino; Kurt Hamacher; Heinz H Coenen; Martin Westhofen; Michael Eble; Ulrich Buell; Patrick Reinartz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-14       Impact factor: 9.236

8.  Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.

Authors:  Dian Wang; Christopher J Schultz; Paul A Jursinic; Mirek Bialkowski; X Ronald Zhu; W Douglas Brown; Scott D Rand; Michelle A Michel; Bruce H Campbell; Stuart Wong; X Allen Li; J Frank Wilson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-01       Impact factor: 7.038

9.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.

Authors:  Michael K M Kam; Sing-Fai Leung; Benny Zee; Ricky M C Chau; Joyce J S Suen; Frankie Mo; Maria Lai; Rosalie Ho; Kin-yin Cheung; Brian K H Yu; Samuel K W Chiu; Peter H K Choi; Peter M L Teo; Wing-hong Kwan; Anthony T C Chan
Journal:  J Clin Oncol       Date:  2007-11-01       Impact factor: 44.544

10.  FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.

Authors:  Letizia Deantonio; Debora Beldì; Giuseppina Gambaro; Gianfranco Loi; Marco Brambilla; Eugenio Inglese; Marco Krengli
Journal:  Radiat Oncol       Date:  2008-09-18       Impact factor: 3.481
View more
  1 in total

1.  The cellular basis of increased PET hypoxia tracer uptake in focal cerebral ischemia with comparison between [18F]FMISO and [64Cu]CuATSM.

Authors:  Philip V Little; Fabian Arnberg; Emma Jussing; Li Lu; Andreas Ingemann Jensen; Nicholas Mitsios; Jan Mulder; Thuy A Tran; Staffan Holmin
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.